18 Share Tips – 16th March 2026

Welcome to this week’s edition of 18 Share Tips – our weekly selection of top ASX shares, chosen by leading analysts, that we think are worth considering.

This week Toby Grimm of Baker Young, Niv Dagan of Peak Asset Management and Nathan Lodge of Securities Vault share their ‘Buy’, ‘Hold’ and ‘Sell’ recommendations.

Please note these share tips are simply recommendations and are in no way intended as financial advice. These share tips are general advice and don’t take into account any individual’s financial situation. Investors are advised to seek professional financial advice before investing.

Early Access to 18 Share Tips

Every Monday at 9AM, thousands of investors scramble to read the same tips at the same time. Prices move. Opportunities disappear. You’re always one step behind.

But with The Bull Premium you get access to 18 Share Tips on Friday morning, giving you 3 extra days to prepare.

So while others read Monday’s tips, you’re already positioned to win.

Toby Grimm, Baker Young

BUY RECOMMENDATIONS

BUY – QBE Insurance Group (QBE)

QBE offers attractive value at this stage of the cycle. In February, the global insurer reported better-than-forecast earnings growth of 23 per cent in full year 2025, driven by a solid 7 per cent increase in policy sales and relatively low claims rates. With favourable operating conditions likely to persist into full year 2026, we see compelling financial sector value at around 11.5 times projected earnings and a dividend yield of 5 per cent. Insurance is inherently risky and industry feedback suggests competition is increasing, which may limit further premium increases in coming years. However, QBE offers unparalleled geographical diversification among Australian insurers, which helps reduce earnings volatility. We’re comfortable accumulating the stock at current levels as an attractively valued, well diversified financial exposure.

BUY – CAR Group (CAR)

This online automotive marketplace operator posted stronger-than-expected first half results for 2026. It grew revenue by 13 per cent and reported EBITDA by 11 per cent. Recent sector-wide selling driven largely by concerns around potential artificial intelligence (AI) disruption has weighed on valuations. However, we believe CAR’s trusted brands, established distribution network and strong dealer relationships position it well to integrate AI tools into its services rather than be disrupted by them. Over time, AI could enhance listing quality, pricing transparency and advertising effectiveness across its platforms. Given the company’s strong market position, attractive margins and long runway for digital automotive marketplace growth across several geographies, we view recent price weakness as an opportunity to accumulate a high quality technology-enabled marketplace at a more reasonable valuation.

HOLD RECOMMENDATIONS

HOLD – Life360 Inc. (360)

Life360 is a leading family safety and location sharing platform operating across the US, UK and Australia. The company delivered better-than-expected full year results in 2025, highlighted by subscription revenue increasing 33 per cent. Hardware remains an important long term growth option, as it helps lock users into paid subscriptions. We believe the magnitude of the recent share price decline has been excessive given the strength across most of Life360’s core subscription business. Accordingly, we remain comfortable holding this high quality, fast growing and profitable company at current levels.

HOLD – Endeavour Group (EDV)

The drinks and hotels operator delivered solid first half results for fiscal year 2026. Hotel sales increased by 4.4 per cent and total retail sales increased by 0.2 per cent. Hotel sales growth in the first seven weeks of the second half of fiscal year 2026 was up 4.5 per cent followed by 1.3 per cent for retail sales. The company is investing heavily in price competition to support volumes, which will likely pressure margins in the near term. While it may be too early to call a full recovery, we believe risks are broadly balanced and we’re comfortable maintaining our position ahead of the strategic update.

SELL RECOMMENDATIONS

SELL – Downer EDI (DOW)

Downer provides integrated services that maintains infrastructure across Australia and New Zealand. It’s benefited from highly supportive macroeconomic conditions and favourable government infrastructure spending during the past two years. The company’s first half result in fiscal year 2026 highlighted statutory net profit after tax of $98 million, up 29.8 per cent on the prior corresponding period. Management expects further margin expansion through fiscal years 2026 and 2027. However, the share price increase has far outpaced underlying earnings growth. At current valuation levels, we see limited margin for error and little valuation support should conditions soften. Consequently, we believe it’s prudent to take profits. 

SELL – Magellan Financial Group (MFG)

Shares in this funds management firm have rallied following news it will merge with boutique investment bank Barrenjoey Capital Partners. While we recognise the strategic rationale of diversifying away from the increasingly challenging funds management industry, and view Barrenjoey as an attractive and growing participant in Australian capital markets, we question the valuation implied by the transaction. The deal effectively values the business around 15 times underlying earnings. Also, the transaction involves issuing MFG shares at $8.45 each to partially fund the acquisition, creating meaningful dilution for existing shareholders. Given the strong share price reaction to the announcement, we would consider taking advantage of the rally to exit positions.

The contributor, their employer, and their associates may hold interests in, receive benefits from, or have relationships with the securities mentioned that could influence the views expressed.

Niv Dagan, Peak Asset Management

BUY RECOMMENDATIONS

BUY – Eden Innovations (EDE)

EDE is an industrial technology company. Its technologies are used across construction, concrete production, power generation and other industrial infrastructure applications. The company has generated more than $30 million in lifetime sales. Recent developments marked a meaningful shift in Eden’s financial position. The company raised $4.35 million in the second quarter of full year 2026. It has reduced debt by $16 million since June 30, 2025. In our view, the focus has shifted from re-capitalisation to commercial growth. We recommend EDE as a buy for investors comfortable with small market capitalisation risk and seeking exposure to durable infrastructure and the growing energy decarbonisation themes.

BUY – Tasman Resources (TAS)

Tasman is an explorer with strategic exposure to precious and base metals across South Australia’s highly prospective Gawler Craton. Tasman’s flagship Lake Torrens IOCG (iron-oxide-copper-gold) project is near BHP Group’s Olympic Dam operation, one of the world’s most significant IOCG discoveries. Tasman operates Lake Torrens through a farm-in and joint venture with Fortescue (FMG). Recent exploration results have strengthened the investment case. Fortescue’s magnetotelluric survey at Titan West identified a large deep conductor at about 620 metres, consistent with IOCG-style mineralisation. Tasman’s shareholding in Eden Innovations provides exposure to a US clean technology business. Our recommendation is supported by strategic validation from the Fortescue partnership and highly prospective IOCG tenure at Lake Torrens. 

HOLD RECOMMENDATIONS

HOLD – Eclipse Metals (EPM)

The company focuses on exploration in Greenland and Australia. The company upgraded its inferred mineral resource estimate at the Gronnedal prospect in Greenland to 89.2 million tonnes, containing total rare earth oxides of 567,000 tonnes, a significant increase from the maiden resource. Metallurgical test work at Gronnedal has shown the ore responds well to simple processing. EPM offers a globally significant resource in a secure jurisdiction. Further testing  will determine how much of the geological and technical upside can be credibly translated into project value. On January 30, 2026, EPM announced it was continuing to pursue a listing on the NASDAQ Stock Market to enhance global visibility and accessibility to North American investors.

HOLD – NoviqTech (NVQ)

NoviqTech uses artificial intelligence and distributed ledger technology to deliver transparent reporting across supply chains, carbon emissions and guarantee of origin. The company signed a formal agreement with Viva Energy Australia to support its sustainable aviation fuel (SAF) book and claim project, which is partly funded by the Australian Renewable Energy Agency (ARENA). We view the company’s strategic positioning as a positive. The Viva Energy collaboration provides early validation of infrastructure capabilities, and supports NVQ’s positioning as a technology provider within an active environmental market.

SELL RECOMMENDATIONS

SELL – Nuix (NXL)

Nuix is an investigative analytics software provider. It enables customers to process and search large data sets of unstructured information, including emails, documents and communications records. The company earns most of its revenue from licence and maintenance fees. Revenue of $121.2 million in the first half of fiscal year 2026 was up 15.2 per cent on the prior corresponding period. Annualised contract value of $234.4 million was up 8.4 per cent. Investors may want to consider taking a profit as we believe gains are priced in following the half year result. We see limited scope for upside amid increasing competition.

SELL – BrainChip Holdings (BRN)

BrainChip is a commercial producer of neuromorphic artificial intelligence (AI). The company operates across Australia, the US and Europe and had a market capitalisation of  about $A349.17 million during trading on March 12. The broader AI hardware landscape is increasingly dominated by big players, such as Nvidia. The AI sector is intensively competitive. The company substantially lifted revenue in full year 2025, but reported a loss from continuing operations after tax. The shares have fallen from 24.5 cents on October 9, 2025 to trade at 14 cents on March 12. Other stocks appeal more at this stage of the cycle.

Nathan Lodge, Securities Vault

BUY RECOMMENDATIONS

BUY – Eastern Gas Corporation (EGA)

The company offers leveraged exposure to Australia’s tightening east coast gas market. Given domestic supply constraints persisting and energy security back in focus, emerging gas developers are attracting increasing investor attention. EGA’s strategy centres on advancing conventional gas assets towards production, positioning the company to benefit from sustained gas pricing and structural demand. With a relatively modest market capitalisation amid sector tailwinds, EGA provides potential upside if development milestones are delivered. For investors seeking exposure to the domestic energy security theme, EGA represents an early stage opportunity with a possible valuation re-rating as the market recognises its production pathway. I own shares in EGA. 

BUY – Rent.com.au (RNT)

RNT is positioning itself as a specialist platform within Australia’s big and evolving rental market. While dominant property portals, such as REA Group and Domain Holdings Australia, focus heavily on property advertising for agents and landlords, RNT has built its model around the renter.  Products such as RentPay, RentConnect and RentBond aim to create additional revenue streams beyond simple listing fees. If executed successfully, this ecosystem approach could increase customer lifetime value, while embedding the platform deeper into the rental journey. Rental demand remains buoyant. 

HOLD RECOMMENDATIONS

HOLD – ResMed Inc (RMD)

ResMed remains a global leader in sleep apnoea devices and digital health monitoring. Structural demand drivers, including ageing populations, increasing diagnosis rates and broader awareness of sleep health, continue to support long term growth. However, a strong share price recovery following concerns about the impact of weight loss drugs on sleep apnoea treatment appears to leave much of the near-term optimism priced into the stock. While the company’s fundamentals remain robust, the valuation reflects its market leadership and growth outlook. Investors may prefer to retain existing positions, while awaiting further earnings expansion, or more attractive entry points.

HOLD – Starpharma Holdings (SPL)

SPL is a biotechnology company focused on advancing dendrimer-based medicines and drug delivery technologies. The technology aims to improve the delivery and efficacy of existing pharmaceutical compounds, creating potential licensing opportunities with global pharmaceutical partners. The valuation tends to move in cycles tied to trial results, licensing deals and capital market conditions. The shares have risen from 13 cents on September 18, 2025 to trade at 38.5 cents on March 12, 2026.

SELL RECOMMENDATIONS

SELL – Optiscan Imaging (OIL)

The company develops real time digital microscopic imaging technologies designed to enable medical diagnostics and surgical applications. The company’s valuation has periodically moved on the back of technology announcements, partnerships and product development updates, but consistent and meaningful revenue growth is yet to follow. As with many early-stage medical technology companies, commercialisation cycles can be long and capital intensive, requiring ongoing investment in product development, regulatory approvals and clinical validation. While Optiscan’s technology platform may hold long term promise, the company sits in our sell category until clearer evidence of commercial traction emerges.

SELL – Lunnon Metals (LM8)

Lunnon Metals is a Western Australian nickel explorer with assets located within the prolific Kambalda district. The company’s strategy centres on exploring and advancing sulphide nickel deposits in a region historically known for high grade discoveries and established mining infrastructure. However, global nickel prices have been under sustained pressure as supply from Indonesia has increased rapidly, creating a structural oversupply in the market. For companies, such as Lunnon Metals, exploration success isn’t sufficient to drive value if the underlying commodity price environment remains weak.

The above recommendations are general advice and don’t take into account any individual’s objectives, financial situation or needs. Investors are advised to seek their own professional advice before investing. Please note that TheBull.com.au simply publishes broker recommendations on this page. The publication of these recommendations does not in any way constitute a recommendation on the part of TheBull.com.au. You should seek professional advice before making any investment decisions.